This document discusses the global market for nanomedicine. It begins by describing how nanotechnology has changed perspectives in science and healthcare, with potential applications in drug delivery, gene mimicking, diagnostics, and more. However, moving nanotechnology from the lab to approved products is an expensive, long process due to regulatory hurdles. While the future market seems promising, these challenges make investors reluctant to fund large projects. The document then reviews various types of nanomaterials and their uses, as well as market projections showing continued high growth in the nanomedicine sector driven primarily by anticancer drugs. Barriers to financing nanotechnology development are also discussed.